Impinj, Inc. reported first‑quarter 2026 revenue of $74.3 million, unchanged from the same period a year earlier, and a net loss of $25.3 million, or $0.83 per share. Adjusted earnings per share were $0.14, a decline from $0.21 in Q1 2025 but a $0.03 beat over the consensus estimate of $0.11. The company’s revenue flatness masks a 20% sequential decline from $92.8 million in Q4 2025, driven by a drop in systems revenue and a modest decline in endpoint IC sales.
The company’s non‑GAAP gross margin fell to 52.4% from 52.7% a year earlier, reflecting a shift toward the higher‑margin M800 endpoint IC family but also higher indirect costs, a 2025 price decline for endpoint ICs, and a one‑time production issue that reduced margin in the quarter. The mix shift to M800, while improving margin contribution, was offset by the cost pressures and the price decline, resulting in a 2.3‑percentage‑point contraction from the prior year.
Segment‑level revenue shows endpoint ICs generated $63.2 million, up 3% from $61.2 million in Q1 2025, while systems revenue fell to $11 million from $13.1 million a year earlier. The flat overall revenue is largely due to the decline in systems sales, which counterbalanced the growth in endpoint ICs. The sequential 20% drop in total revenue is largely attributable to the 20% decline in systems revenue from Q4 2025.
The widened GAAP net loss was largely driven by an induced conversion expense of $11.9 million related to the repurchase of $40.2 million of convertible notes in March 2026, in addition to one‑time restructuring charges. These non‑operational items increased the GAAP loss beyond the analyst estimate of a $0.38 loss per share, while the underlying operating performance remained strong as reflected in the adjusted EPS beat.
Management guided for second‑quarter 2026 revenue of $103 million to $106 million and adjusted earnings per share of $0.77 to $0.82, well above consensus estimates. The guidance signals confidence that demand for the company’s Gen2X‑enabled solutions will rebound as inventory levels normalize and the M800 ramp continues. The company’s CEO and CFO emphasized record endpoint IC bookings and a return to profitability as inventory corrections subside, underscoring the strategic focus on higher‑margin products and market‑share gains.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.